lost in melb. (10-27-2020)
By Joe Tacopino - New York Post
President Trump plans to announce an initiative to issue early vaccines for COVID-19 free of cost to recipients of Medicare and Medicaid, a report said on Monday.
The administration is expected to announce a plan to cover vaccines that receive emergency use authorization from the Food and Drug Administration, according to Politico.
The change could help millions receive a coronavirus vaccine for free.
The Centers for Medicare and Medicaid Services is expected to make an announcement about the plan on Tuesday or Wednesday, the newspaper said.
The administration is “working to ensure that no American has to pay for the vaccine,” one official told the outlet.
A number of vaccines are in production. A vaccine being developed by scientists at Oxford University and drugmaker AstraZeneca is considered the likeliest candidate to be used first.
Dr. Anthony Fauci said experts will know “by the end of November, the beginning of December” whether a coronavirus vaccine is safe and effective. Fauci, however, added that it won’t be widely available until next year.
https://www.fda.gov/media/134922/download
>>285569402 (OP)
It's like flu like symptoms were exosomes all along!
Old question, but has anyone isolated it
https://www.whatdotheyknow.com/reque...V%202.pdf.html
'Considering the consequences to this country’s people, economy and way of life, it is absolutely incredible to learn that Public Health England has no documented independent evidence of its own that this virus has been properly isolated and properly identified.'—Andrew Johnson.
Jessica Elgot and Heather Stewart - The Guardian
The UK should be braced for at least a third wave of the coronavirus pandemic and further lockdowns, a minister has said as Tory sceptics warned they would not vote to extend England’s four-week shutdown.
Penny Mordaunt, the paymaster general, told MPs on Tuesday that there could yet be a rolling series of lockdowns – but argued this was not evidence that the measure was ineffective.
It came as the former chief whip, Mark Harper, criticised a lack of engagement with Conservative backbenchers before a Commons vote on England’s lockdown on Wednesday, and said the government would be forced to rely on Labour votes to pass any extension beyond 2 December.
Ministers expect a moderate number of Conservative MPs to rebel but Labour support means the measures are guaranteed to pass.
Speaking in parliament, Mordaunt said the government was “hopeful of being able to unlock in December but they are being driven by the data”. She said cases would inevitably rise after restrictions are lifted, and a high proportion of the population will remain vulnerable to the virus.
“That is why some scientists expect a third or more waves of the virus to be managed [with] repeat lockdowns. Others argue that the need for future lockdowns is evidence they don’t work but that’s to misunderstand what they are there to do,” she said.
“This approach buys us time and is the optimum use of the healthcare we have in the meantime while capacity is built and vaccines are sought.”
Her remarks contrasted with those of Boris Johnson, who was bullish that England’s lockdown would end on 2 December, telling a cabinet meeting on Tuesday that this was a hard deadline to develop a new solution to contain the spread of the virus.
The prime minister also appeared to affirm that the government expected the four-week lockdown to be enough to get the virus’s R number below 1 – raising questions as to whether the lockdown would be extended should that not occur.
“Once again we are, alas, asking everybody to stay at home to protect the NHS, to save lives, and get the R down below 1. I know we can, I know we will. It’s only just above 1 at the moment,” he said.
Harper said he had not received the reassurances he had repeatedly requested about the projections used by Johnson to justify the lockdown. He said he had not yet decided whether to support the government on Wednesday but predicted most colleagues would reluctantly back the plan, though the prime minister would struggle to secure support for any extension next month.
“If the government do need to extend these measures, I think it’s very clear that they would end up depending on the votes of the Labour party – and prime ministers who end up depending on the opposition tend to end badly, in my experience.”
James Grundy, the MP for Leigh in Greater Manchester – Andy Burnham’s old seat and a Labour stronghold for 114 years until December – said he planned to vote against the government unless financial support improved significantly or there was a clear timetable for a vaccine.
“A rolling series of lockdowns might … hold Covid-19 at bay for a few weeks, or months, as the last one did. Then again, it might not. It certainly will cause absolute devastation to every other part of our society though,” he said.
Conservative lockdown sceptics criticised the government’s strategy during a debate in Westminster Hall, to which Mordaunt was responding. The backbencher Richard Drax said the government had overreacted to the pandemic.
“A draconian, onerous and invasive set of rules and regulations now govern our very existence,” he said. “I cannot recall a moment in our proud island history where our nation has been so cowed to the extent it is now.”
The Tory MP Bob Seeley said anyone who believed restrictions would end on 2 December was “living in a parallel universe … You really wonder if the government is losing the plot over this.”
Chris Green, the Conservative MP for Bolton, said the response had been “erratic”, and the regional tiered system had not been given enough time to have an effect.
By Amanda Prestigiacomo - The Daily Wire
A new study from Danish researchers found that mask-wearers were not protected from becoming infected by the novel coronavirus more than their mask-less counterparts, contradicting the mainstream consensus, including that of the U.S. Centers for Disease Control and Prevention (CDC).
“Researchers in Denmark reported on Wednesday that surgical masks did not protect the wearers against infection with the coronavirus in a large randomized clinical trial,” The New York Times reported Wednesday.
The Times noted that the study, published in the Annals of Internal Medicine, “did not contradict growing evidence that masks can prevent transmission of the virus from wearer to others,” though its “conclusion is at odds with the view that masks also protect the wearers — a position endorsed just last week by the Centers for Disease Control and Prevention.”
The study was comprised of 4,862 total participants; about half were directed to wear masks in public, and the other half were told not to.
Through antibody testing, it was found that COVID-19 occurred in 42 participants (1.8%) who wore masks, and in 53 participants (2.1%) who did not wear masks – the “control participants.”
The researchers concluded that the difference between the groups was statistically insignificant.
“Our study gives an indication of how much you gain from wearing a mask,” said lead author of the study Dr. Henning Bundgaard. “Not a lot.”
Dr. Christine Laine, Editor-in-Chief of the Annals of Internal Medicine, noted that study underscores that masks “are not a magic bullet.”
“There are people who say, ‘I’m fine, I’m wearing a mask.’ They need to realize they are not invulnerable to infection,” she emphasized.
“The study’s conclusion flies in the face of other research suggesting that masks do protect the wearer,” the Times highlighted. “In its recent bulletin, the C.D.C. cited a dozen studies finding that even cloth masks may help protect the wearer. Most of them were laboratory examinations of the particles blocked by materials of various types.”
Indeed, the CDC has stated on their site: “Data regarding the ‘real-world’ effectiveness of community masking are limited to observational and epidemiological studies.”
The Times also cited pushback against the study, namely over the low rate of infection in Denmark at the time of the trial and the participants self-reporting, meaning their mask-wearing was not independently verified:
Other experts were unconvinced. The incidence of infections in Denmark was lower than it is today in many places, meaning the effectiveness of masks for wearers may have been harder to detect, they noted.
Participants reported their own test results; mask use was not independently verified, and users may not have worn them correctly.
“The question this study was designed to answer is: Do they work as personal protection?” said Dr. Thomas Frieden, chief executive of Resolve to Save Lives and former CDC director.
According to Frieden, the Times said, the answer to that question was not “teased out” in the study and “depends on what mask is used and what sort of exposure to the virus each person has.”
“An N95 mask is better than a surgical mask,” Dr. Frieden posited. “A surgical mask is better than most cloth masks. A cloth mask is better than nothing.”
Griffin (11-19-2020)
looks like Australia pissed China off
https://www.abc.net.au/news/health/2...gious/12896262
either that or it looks like orange man might defeat the banksters, so covid21 time
FBD (11-21-2020), lost in melb. (11-21-2020)
By Bojan Pancevski, Jenny Strasburg, Jared S. Hopkins | The Wall Street Journal
LONDON—The U.K. became the first Western nation to grant emergency-use authorization for a Covid-19 vaccine, clearing a shot developed by Pfizer Inc. of the U.S. and BioNTech SE of Germany to be distributed in limited numbers within days.
The two-shot vaccine is also being reviewed by the Food and Drug Administration in the U.S., where a similar authorization could come later this month and a rollout before the end of the year.
The U.K. green light punctuates a monthslong sprint by the two drugmakers, which teamed up earlier this year and then pulled ahead of two other Western pharmaceutical giants, each with its own promising shot. Vaccines typically take years to bring to market.
It also marks a key milestone in efforts to translate a promising new vaccine technology into a widely available shot. It was developed, tested, authorized and is now poised to be distributed amid a pandemic that has sickened tens of millions of people and killed more than 1.4 million around the world.
The U.K. has ordered 40 million doses, enough to vaccinate 20 million people. The government said in early November it expected to receive 10 million doses before year-end. People familiar with the matter said the U.K. might only get four million to five million does this year, but the number is in flux and will depend on production and other potential regulatory authorizations.
lost in melb. (12-02-2020)
I'm happy for people to go ahead and trial this stuff get vaccinated before I do
Teh One Who Knocks (12-02-2020)
Yeah, even though the preliminary reports look good, there is a part of me that worries about side effects that could show up once the vaccination goes into widespread use. I wouldn't be surprised if you are required to sign a waiver to get the vaccine holding the pharmaceutical company free from liability for any "unforeseen" side effects that may appear.
FBD (12-02-2020), lost in melb. (12-02-2020)